Hypoxia-Inducible Factor-1 as a Therapeutic Target in Endometrial Cancer Management
In the Western world, endometrial cancer (EC) is the most common malignant tumor of the female genital tract. Solid tumors like EC outgrow their vasculature resulting in hypoxia. Tumor hypoxia is important because it renders an aggressive phenotype and leads to radio- and chemo-therapy resistance. H...
Saved in:
Main Authors: | Laura M. S. Seeber, Ronald P. Zweemer, René H. M. Verheijen, Paul J. van Diest |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | Obstetrics and Gynecology International |
Online Access: | http://dx.doi.org/10.1155/2010/580971 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hypoxia and Angiogenesis in Endometrioid Endometrial Carcinogenesis
by: Nicole Horrée, et al.
Published: (2007-01-01) -
Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity
by: Brian M Ortmann
Published: (2024-07-01) -
Hypoxia-Induced Autophagy Enhances Cisplatin Resistance in Human Bladder Cancer Cells by Targeting Hypoxia-Inducible Factor-1α
by: Xiawa Mao, et al.
Published: (2021-01-01) -
Time, location and function of hypoxia-inducible factors are critical to therapeutic tumour response
by: Laure Marignol, et al.
Published: (2024-07-01) -
Molecular Alterations of PI3K/Akt/mTOR Pathway: A Therapeutic Target in Endometrial Cancer
by: Athanasia Pavlidou, et al.
Published: (2014-01-01)